GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,036 Cr | ₹928 Cr | ₹590 Cr | ₹608 Cr | ₹381 Cr |
What is the latest Profit After Tax of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹1,036 Cr |
| Mar2025 | ₹928 Cr |
| Mar2024 | ₹590 Cr |
| Mar2023 | ₹608 Cr |
| Mar2022 | ₹381 Cr |
How is Profit After Tax of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,036 Cr | 11.69 | |
| Mar2025 | ₹928 Cr | 57.23 | |
| Mar2024 | ₹590 Cr | -2.91 | |
| Mar2023 | ₹608 Cr | 59.58 | |
| Mar2022 | ₹381 Cr | - | |
Compare Profit After Tax of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹49,642.7 Cr | 1.6% | 16.6% | 4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.6% |
16.6% |
4% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses